Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23703226 | 0.80 | HTT (0.39) | HTTALDH1A1HPGDL3MBTL1GAA | |
| SCHEMBL17743470 | 0.79 | HTT (0.38) | HTTALDH1A1HPGDL3MBTL1GAA | |
| SCHEMBL30236538 | 0.78 | RAPGEF4 (0.44) | HTTALDH1A1HPGDL3MBTL1GAA | |
| SCHEMBL1607815 | 0.78 | RAPGEF4 (0.44) | HTTALDH1A1HPGDL3MBTL1GAA | |
| Butane SCHEMBL8819824 | 0.78 | PGK1 (0.43) | HTTALDH1A1HPGDL3MBTL1GAA | |
| Water SCHEMBL27145442 | 0.76 | RAPGEF4 (0.43) | HTTALDH1A1HPGDL3MBTL1GAA | |
| SCHEMBL909723 | 0.76 | MEN1 (0.46) | HTTALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL5189165 | 0.75 | TDP1 (0.45) | ALDH1A1L3MBTL1GAAMEN1KMT2A | |
| SCHEMBL1180196 | 0.74 | GAA (0.41) | ALDH1A1HPGDL3MBTL1GAAMEN1 | |
| SCHEMBL30716894 | 0.74 | AMY1A (0.44) | HTTALDH1A1HPGDL3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9441072-B2 | Metal colloids with accessible metal surfaces | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-09-13 | — | — | US | disclosed |
| US-20120316347-A1 | METAL COLLOIDS WITH ACCESSIBLE METAL SURFACES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-13 | — | — | US | disclosed |
| EP-2496350-A1 | METAL COLLOIDS WITH ACCESSIBLE METAL SURFACES | The Regents Of The University Of California (US) | 2012-09-12 | — | — | EP | disclosed |
| WO-2011057109-A1 | METAL COLLOIDS WITH ACCESSIBLE METAL SURFACES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316347-A1 | METAL COLLOIDS WITH ACCESSIBLE METAL SURFACES | CALR, CALD1, CALU | HTT 2433/4885ALDH1A1 1519/4885HPGD 3424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.